Literature DB >> 12223075

Using Drosophila melanogaster to uncover human disease gene function and potential drug target proteins.

Lawrence T Reiter1, Ethan Bier.   

Abstract

The fruit fly Drosophila melanogaster is a powerful genetic model organism, which has been instrumental in the determination of essential developmental and neurological pathways conserved from invertebrates to humans. With the completion of both the human and Drosophila genomes, the revelation that we are more similar to this simple organism than previously suspected was realised. 75% of human genetic disease genes have clear homologues in the fly. By utilising an array of genetic tools available to disrupt or misexpress these proteins, it is now feasible to perform large-scale genetic screens in Drosophila to identify other members of a particular human genetic pathway. This review outlines some of the reasons Drosophila is a useful tool for the discovery of therapeutic targets, covers some of the tools available to manipulate this organism and discusses specific examples of how to use Drosophila as a genetic test tube for revealing proteins which act in a common pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223075     DOI: 10.1517/14728222.6.3.387

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  15 in total

Review 1.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

2.  Drak/STK17A Drives Neoplastic Glial Proliferation through Modulation of MRLC Signaling.

Authors:  Alexander S Chen; Joanna Wardwell-Ozgo; Nilang N Shah; Deidre Wright; Christina L Appin; Krishanthan Vigneswaran; Daniel J Brat; Harley I Kornblum; Renee D Read
Journal:  Cancer Res       Date:  2018-12-10       Impact factor: 12.701

Review 3.  Viruses and antiviral immunity in Drosophila.

Authors:  Jie Xu; Sara Cherry
Journal:  Dev Comp Immunol       Date:  2013-05-13       Impact factor: 3.636

4.  A hormone-dependent module regulating energy balance.

Authors:  Biao Wang; Noel Moya; Sherry Niessen; Heather Hoover; Maria M Mihaylova; Reuben J Shaw; John R Yates; Wolfgang H Fischer; John B Thomas; Marc Montminy
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

5.  A protocol for genetic induction and visualization of benign and invasive tumors in cephalic complexes of Drosophila melanogaster.

Authors:  Ajay Srivastava
Journal:  J Vis Exp       Date:  2013-09-11       Impact factor: 1.355

Review 6.  Drosophila melanogaster as a model system for human brain cancers.

Authors:  Renee D Read
Journal:  Glia       Date:  2011-05-02       Impact factor: 7.452

Review 7.  Drosophila sodium channel mutations: Contributions to seizure-susceptibility.

Authors:  Jason R Kroll; Arunesh Saras; Mark A Tanouye
Journal:  Exp Neurol       Date:  2015-06-18       Impact factor: 5.330

8.  Hyperactive BMP signaling induced by ALK2(R206H) requires type II receptor function in a Drosophila model for classic fibrodysplasia ossificans progressiva.

Authors:  Viet Q Le; Kristi A Wharton
Journal:  Dev Dyn       Date:  2012-01       Impact factor: 3.780

Review 9.  Drosophila as an In Vivo Model for Human Neurodegenerative Disease.

Authors:  Leeanne McGurk; Amit Berson; Nancy M Bonini
Journal:  Genetics       Date:  2015-10       Impact factor: 4.562

10.  A drosophila model for EGFR-Ras and PI3K-dependent human glioma.

Authors:  Renee D Read; Webster K Cavenee; Frank B Furnari; John B Thomas
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.